Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Effect of storage time on gene expression data acquired from unfrozen archived newborn blood spots.

Ho NT, Busik JV, Resau JH, Paneth N, Khoo SK.

Mol Genet Metab. 2016 Nov;119(3):207-213. doi: 10.1016/j.ymgme.2016.08.001. Epub 2016 Aug 18.

2.

Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice.

Bar-Lev Y, Moshitch-Moshkovitz S, Tsarfaty G, Kaufman D, Horev J, Resau JH, Tsarfaty I.

PLoS One. 2016 Jun 30;11(6):e0157850. doi: 10.1371/journal.pone.0157850. eCollection 2016.

3.

Veterinary and human biobanking practices: enhancing molecular sample integrity.

Hostetter G, Collins E, Varlan P, Edewaard E, Harbach PR, Hudson EA, Feenstra KJ, Turner LM, Berghuis BD, Resau JH, Jewell SD.

Vet Pathol. 2014 Jan;51(1):270-80. doi: 10.1177/0300985813510532. Epub 2013 Nov 13.

PMID:
24227009
4.

Mycoplasmosis in ferrets.

Kiupel M, Desjardins DR, Lim A, Bolin C, Johnson-Delaney CA, Resau JH, Garner MM, Bolin SR.

Emerg Infect Dis. 2012 Nov;18(11):1763-70. doi: 10.3201/eid1811.120072.

5.

Evaluation of sex-specific gene expression in archived dried blood spots (DBS).

Resau JH, Ho NT, Dykema K, Faber MS, Busik JV, Nickolov RZ, Furge KA, Paneth N, Jewell S, Khoo SK.

Int J Mol Sci. 2012;13(8):9599-608. doi: 10.3390/ijms13089599. Epub 2012 Aug 2.

6.

Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.

Cao Y, Zhang ZL, Zhou M, Elson P, Rini B, Aydin H, Feenstra K, Tan MH, Berghuis B, Tabbey R, Resau JH, Zhou FJ, Teh BT, Qian CN.

Cancer. 2013 Jan 15;119(2):313-24. doi: 10.1002/cncr.27746. Epub 2012 Jul 18.

7.

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.

Monsma DJ, Monks NR, Cherba DM, Dylewski D, Eugster E, Jahn H, Srikanth S, Scott SB, Richardson PJ, Everts RE, Ishkin A, Nikolsky Y, Resau JH, Sigler R, Nickoloff BJ, Webb CP.

J Transl Med. 2012 Jun 18;10:125. doi: 10.1186/1479-5876-10-125.

8.

Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.

Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, Forsgren L, Neuman LA, Tan AC.

J Parkinsons Dis. 2012;2(4):321-31. doi: 10.3233/JPD-012144.

PMID:
23938262
9.

Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors.

Malapaka RR, Khoo S, Zhang J, Choi JH, Zhou XE, Xu Y, Gong Y, Li J, Yong EL, Chalmers MJ, Chang L, Resau JH, Griffin PR, Chen YE, Xu HE.

J Biol Chem. 2012 Jan 2;287(1):183-95. doi: 10.1074/jbc.M111.294785. Epub 2011 Oct 28.

10.

Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.

Zhao YY, Xue C, Jiang W, Zhao HY, Huang Y, Feenstra K, Resau JH, Qian CN, Zhang L.

J Thorac Oncol. 2012 Jan;7(1):71-5. doi: 10.1097/JTO.0b013e31823085f4.

11.
12.

Serum adiponectin, resistin, and circulating soluble receptor for advanced glycation end products in colectomy patients.

Asgeirsson T, Zhang S, Khoo SK, Resau JH, Dujovny N, Senagore AJ.

Mediators Inflamm. 2011;2011:916807. doi: 10.1155/2011/916807. Epub 2011 Sep 7.

13.

Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.

He Y, Xu Y, Zhang C, Gao X, Dykema KJ, Martin KR, Ke J, Hudson EA, Khoo SK, Resau JH, Alberts AS, MacKeigan JP, Furge KA, Xu HE.

Sci Signal. 2011 Jul 5;4(180):ra44. doi: 10.1126/scisignal.2001450.

14.

Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine.

Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP 2nd.

J Biomed Mater Res A. 2011 Sep 1;98(3):425-33. doi: 10.1002/jbm.a.33130. Epub 2011 May 31.

PMID:
21630435
15.

Effects of surface wettability, flow, and protein concentration on macrophage and astrocyte adhesion in an in vitro model of central nervous system catheter obstruction.

Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP 2nd.

J Biomed Mater Res A. 2011 Jun 15;97(4):433-40. doi: 10.1002/jbm.a.33078. Epub 2011 Apr 11.

PMID:
21484987
16.

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.

Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, Teh BT, MacKeigan JP.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1439-44. doi: 10.1073/pnas.1012500108. Epub 2011 Jan 10.

17.

Acquiring genome-wide gene expression profiles in Guthrie card blood spots using microarrays.

Khoo SK, Dykema K, Vadlapatla NM, LaHaie D, Valle S, Satterthwaite D, Ramirez SA, Carruthers JA, Haak PT, Resau JH.

Pathol Int. 2011 Jan;61(1):1-6. doi: 10.1111/j.1440-1827.2010.02611.x.

PMID:
21166936
18.

VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma.

Li Y, Zhang ZF, Chen J, Huang D, Ding Y, Tan MH, Qian CN, Resau JH, Kim H, Teh BT.

Am J Transl Res. 2010 May 20;2(3):296-308.

19.

Mechanical contributions to astrocyte adhesion using a novel in vitro model of catheter obstruction.

Harris CA, Resau JH, Hudson EA, West RA, Moon C, McAllister JP 2nd.

Exp Neurol. 2010 Apr;222(2):204-10. doi: 10.1016/j.expneurol.2009.12.027. Epub 2010 Jan 4.

PMID:
20051241
20.

Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.

Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, Resau JH, Anema J, Kahnoski RJ, Morreau H, Camparo P, Comperat E, Sibony M, Denoux Y, Molinie V, Vieillefond A, Eng C, Williams BO, Teh BT.

Cancer Res. 2009 Nov 1;69(21):8256-64. doi: 10.1158/0008-5472.CAN-09-1689. Epub 2009 Oct 20.

21.

A special key for unlocking the door to targeted therapies of breast cancer.

Lindemann K, Harbeck N, Lengyel E, Resau JH.

ScientificWorldJournal. 2008 Sep 21;8:905-8. doi: 10.1100/tsw.2008.110.

22.

Archived unfrozen neonatal blood spots are amenable to quantitative gene expression analysis.

Haak PT, Busik JV, Kort EJ, Tikhonenko M, Paneth N, Resau JH.

Neonatology. 2009;95(3):210-6. doi: 10.1159/000155652. Epub 2008 Sep 18.

23.

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I.

Neoplasia. 2008 Jun;10(6):521-33.

24.

Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.

Ding Y, Boguslawski EA, Berghuis BD, Young JJ, Zhang Z, Hardy K, Furge K, Kort E, Frankel AE, Hay RV, Resau JH, Duesbery NS.

Mol Cancer Ther. 2008 Mar;7(3):648-58. doi: 10.1158/1535-7163.MCT-07-2229. Epub 2008 Mar 4.

25.

Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.

Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT.

Cancer Res. 2008 Jan 1;68(1):81-8. doi: 10.1158/0008-5472.CAN-07-5311.

26.

The protective effect of the blood brain barrier from systemic cytokines in an animal femur fracture model.

Ott M, Davis AT, Vanderkolk W, Resau JH, Deheer DH, Jones CB, Stouffer C, Kubek EW.

J Trauma. 2007 Sep;63(3):591-5.

PMID:
18073605
27.

Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.

Depeille P, Young JJ, Boguslawski EA, Berghuis BD, Kort EJ, Resau JH, Frankel AE, Duesbery NS.

Clin Cancer Res. 2007 Oct 1;13(19):5926-34.

29.

Inactivation of Apc in the mouse prostate causes prostate carcinoma.

Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO.

Cancer Res. 2007 Mar 15;67(6):2490-6.

30.

LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.

Young JJ, Bromberg-White JL, Zylstra C, Church JT, Boguslawski E, Resau JH, Williams BO, Duesbery NS.

PLoS Pathog. 2007 Mar;3(3):e27.

31.

Prospects for vasculature reorganization in sentinel lymph nodes.

Qian CN, Resau JH, Teh BT.

Cell Cycle. 2007 Mar 1;6(5):514-7. Epub 2007 Mar 2. Review.

PMID:
17329977
32.

Differential oncogenic potential of activated RAS isoforms in melanocytes.

Whitwam T, Vanbrocklin MW, Russo ME, Haak PT, Bilgili D, Resau JH, Koo HM, Holmen SL.

Oncogene. 2007 Jul 5;26(31):4563-70. Epub 2007 Feb 5.

PMID:
17297468
33.

Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.

Yao X, Qian CN, Zhang ZF, Tan MH, Kort EJ, Yang XJ, Resau JH, Teh BT.

Clin Cancer Res. 2007 Jan 1;13(1):161-9.

34.

RhoB and the mammalian Diaphanous-related formin mDia2 in endosome trafficking.

Wallar BJ, Deward AD, Resau JH, Alberts AS.

Exp Cell Res. 2007 Feb 1;313(3):560-71. Epub 2006 Nov 11.

PMID:
17198702
35.

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, Chen J, Resau JH, Teh BT.

Cancer Res. 2006 Nov 1;66(21):10365-76. Epub 2006 Oct 23.

36.

K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin.

Birchenall-Roberts MC, Fu T, Kim SG, Huang YK, Dambach M, Resau JH, Ruscetti FW.

Biochem Biophys Res Commun. 2006 Sep 22;348(2):540-9. Epub 2006 Jul 28.

PMID:
16889753
37.

In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.

Moshitch-Moshkovitz S, Tsarfaty G, Kaufman DW, Stein GY, Shichrur K, Solomon E, Sigler RH, Resau JH, Vande Woude GF, Tsarfaty I.

Neoplasia. 2006 May;8(5):353-63.

38.

HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.

Tsarfaty G, Stein GY, Moshitch-Moshkovitz S, Kaufman DW, Cao B, Resau JH, Vande Woude GF, Tsarfaty I.

Neoplasia. 2006 May;8(5):344-52.

39.

Gene expression in rat lacrimal gland duct cells collected using laser capture microdissection: evidence for K+ secretion by duct cells.

Ubels JL, Hoffman HM, Srikanth S, Resau JH, Webb CP.

Invest Ophthalmol Vis Sci. 2006 May;47(5):1876-85.

PMID:
16638994
40.

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JH, Kiupel M.

Neoplasia. 2006 Feb;8(2):104-11.

41.

Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).

Hay RV, Cao B, Skinner RS, Su Y, Zhao P, Gustafson MF, Qian CN, Teh BT, Knudsen BS, Resau JH, Shen S, Waters DJ, Gross MD, Vande Woude GF.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7064s-7069s.

42.

The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells.

Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, Woodrow M, Resau JH, Courtneidge SA.

Cancer Cell. 2005 Feb;7(2):155-65.

43.

The parafibromin tumor suppressor protein is part of a human Paf1 complex.

Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M.

Mol Cell Biol. 2005 Jan;25(2):612-20.

44.

Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.

Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO.

J Bone Miner Res. 2004 Dec;19(12):2033-40. Epub 2004 Sep 13.

45.

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Vande Woude GF, Harbeck N.

Int J Cancer. 2005 Feb 10;113(4):678-82.

46.

Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways.

Birchenall-Roberts MC, Fu T, Bang OS, Dambach M, Resau JH, Sadowski CL, Bertolette DC, Lee HJ, Kim SJ, Ruscetti FW.

J Biol Chem. 2004 Jun 11;279(24):25605-13. Epub 2004 Apr 2.

47.

Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.

Hay RV, Cao B, Skinner RS, Wang LM, Su Y, Resau JH, Knudsen BS, Gustafson MF, Koo HM, Vande Woude GF, Gross MD.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3839S-44S.

48.

Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor.

Hay RV, Cao B, Skinner RS, Wang LM, Su Y, Resau JH, Vande Woude GF, Gross MD.

Mol Imaging. 2002 Jan-Mar;1(1):56-62.

PMID:
12920861
49.

Quantifying cell scattering: the blob algorithm revisited.

Kort EJ, Jones A, Daumbach M, Hudson EA, Buckner B, Resau JH.

Cytometry A. 2003 Feb;51(2):119-26.

50.

A human tissue and data resource: an overview of opportunities, challenges, and development of a provider/researcher partnership model.

Kort EJ, Campbell B, Resau JH.

Comput Methods Programs Biomed. 2003 Feb;70(2):137-50. Review.

PMID:
12507790

Supplemental Content

Loading ...
Support Center